Literature DB >> 29380872

Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service.

Elizabeth A Stokes1, Sarah Wordsworth1, Julie Staves2, Nicola Mundy3, Jane Skelly4, Kelly Radford5, Simon J Stanworth6,7,8.   

Abstract

BACKGROUND: In an environment of limited health care resources, it is crucial for health care systems which provide blood transfusion to have accurate and comprehensive information on the costs of transfusion, incorporating not only the costs of blood products, but also their administration. Unfortunately, in many countries accurate costs for administering blood are not available. Our study aimed to generate comprehensive estimates of the costs of administering transfusions for the UK National Health Service. STUDY DESIGN AND METHODS: A detailed microcosting study was used to cost two key inputs into transfusion: transfusion laboratory and nursing inputs. For each input, data collection forms were developed to capture staff time, equipment, and consumables associated with each step in the transfusion process. Costing results were combined with costs of blood product wastage to calculate the cost per unit transfused, separately for different blood products. Data were collected in 2014/15 British pounds and converted to US dollars.
RESULTS: A total of 438 data collection forms were completed by 74 staff. The cost of administering blood was $71 (£49) per unit for red blood cells, $84 (£58) for platelets, $55 (£38) for fresh-frozen plasma, and $72 (£49) for cryoprecipitate.
CONCLUSIONS: Blood administration costs add substantially to the costs of the blood products themselves. These are frequently incurred costs; applying estimates to the blood components supplied to UK hospitals in 2015, the annual cost of blood administration, excluding blood products, exceeds $175 (£120) million. These results provide more accurate estimates of the total costs of transfusion than those previously available.
© 2018 AABB.

Mesh:

Year:  2018        PMID: 29380872     DOI: 10.1111/trf.14493

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

Review 1.  Shifting ground and gaps in transfusion support of patients with hematological malignancies.

Authors:  Christine Cserti-Gazdewich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT.

Authors:  David J Beard; Loretta J Davies; Jonathan A Cook; Graeme MacLennan; Andrew Price; Seamus Kent; Jemma Hudson; Andrew Carr; Jose Leal; Helen Campbell; Ray Fitzpatrick; Nigel Arden; David Murray; Marion K Campbell
Journal:  Health Technol Assess       Date:  2020-04       Impact factor: 4.014

3.  Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs.

Authors:  Ivo Beverina; Giancarlo Razionale; Monica Ranzini; Alessandro Aloni; Sergio Finazzi; Bruno Brando
Journal:  Blood Transfus       Date:  2019-12-17       Impact factor: 3.443

4.  Activity Wise Unit Cost of Blood Components in a Tertiary Care Hospital Blood Bank for the Year 2018.

Authors:  Anupa Pokhrel; Kiran Chaudhary; Prerna Sachdeva; Anubhav Gupta; Shilpi Varshney; Harkiran Arora
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-22       Impact factor: 0.900

5.  What is the Economic Cost of Providing an All Wales Postpartum Haemorrhage Quality Improvement Initiative (OBS Cymru)? A Cost-Consequences Comparison with Standard Care.

Authors:  Megan Dale; Sarah F Bell; Susan O'Connell; Cerys Scarr; Kathryn James; Miriam John; Rachel E Collis; Peter W Collins; Grace Carolan-Rees
Journal:  Pharmacoecon Open       Date:  2022-09-06

Review 6.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

7.  Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.

Authors:  Nigel Armstrong; Nasuh Büyükkaramikli; Hannah Penton; Rob Riemsma; Pim Wetzelaer; Vanesa Huertas Carrera; Stephanie Swift; Thea Drachen; Heike Raatz; Steve Ryder; Dhwani Shah; Titas Buksnys; Gill Worthy; Steven Duffy; Maiwenn Al; Jos Kleijnen
Journal:  Health Technol Assess       Date:  2020-10       Impact factor: 4.014

8.  The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program.

Authors:  Cenk İndelen; Yeşim Uygun Kızmaz; Ahmet Kar; Aryeh Shander; Kaan Kırali
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-04-26       Impact factor: 0.332

9.  Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.

Authors:  Jonathan Huber; Simon J Stanworth; Carolyn Doree; Patricia M Fortin; Marialena Trivella; Susan J Brunskill; Sally Hopewell; Kirstin L Wilkinson; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2019-11-28

10.  National comparative audit of red blood cell transfusion practice in hospices: Recommendations for palliative care practice.

Authors:  Karen Neoh; Ross Gray; John Grant-Casey; Lise Estcourt; Catherine Malia; Jason W Boland; Michael I Bennett
Journal:  Palliat Med       Date:  2018-09-27       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.